Micro Therapeutics Inc.
The Irvine maker of medical devices for the diagnosis and treatment of vascular disease reported a net loss of $2.6 million, or 30 cents a share, for the first three months this year, compared with last year’s first-quarter loss of $3.5 million, or 52 cents a share. Quarterly sales grew to $1.1 million from $812,753 last year.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.